Ziegner, UH; Kobayashi, RH; Cunningham-Rundles, C; Español, T; Fasth, A; Huttenlocher, A; ... Ochs, HD; + view all Ziegner, UH; Kobayashi, RH; Cunningham-Rundles, C; Español, T; Fasth, A; Huttenlocher, A; Krogstad, P; Marthinsen, L; Notarangelo, LD; Pasic, S; Rieger, CH; Rudge, P; Sankar, R; Shigeoka, AO; Stiehm, ER; Sullivan, KE; Webster, AD; Ochs, HD; - view fewer (2002) Progressive neurodegeneration in patients with primary immunodeficiency disease on IVIG treatment. Clin Immunol , 102 (1) 19 - 24. 10.1006/clim.2001.5140.
Full text not available from this repository.
We have identified 14 patients with diverse primary immunodeficiencies who have developed progressive neurodegeneration of unknown etiology. All patients had received immunoglobulin replacement therapy for a mean duration of 6.5 years (range of 0.5-13.5 years) at the time of first neurological symptoms. Diagnostic tests of blood and cerebrospinal fluid analyses included chemistry, cultures, PCR for viral genomes, and cytology. In addition, neuroimaging and electrophysiologic studies were performed. Brain tissue histology (n = 5) revealed nonspecific encephalitis with microglial infiltration and neuronal loss. Twelve patients died 6 months to 15 years (median 4.3 years) after onset of neurologic findings. No evidence of any infectious disease that could have explained our patients' progressive encephalopathy was found either during their lifetimes or postmortem. These patients may have had an unusual manifestation of primary immunodeficiency diseases, an autoimmune reaction against neuronal tissue, a yet undefined infectious agent, or a complication of IVIG therapy. To help determine the etiology of this rare complication, an international surveillance system for primary immunodeficiency patients who develop progressive neurodegeneration of unknown cause is recommended.
|Title:||Progressive neurodegeneration in patients with primary immunodeficiency disease on IVIG treatment.|
|Keywords:||Adolescent, Adult, Agammaglobulinemia, Aged, Child, Child, Preschool, Common Variable Immunodeficiency, Communicable Diseases, Europe, European Continental Ancestry Group, Humans, Immunologic Deficiency Syndromes, Middle Aged, Neurodegenerative Diseases, Retrospective Studies, Severe Combined Immunodeficiency, United States|
|UCL classification:||UCL > School of Life and Medical Sciences > Faculty of Brain Sciences > Institute of Neurology|
UCL > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Child Health
Archive Staff Only: edit this record